Juliana Bosso Taniguchi

My research experience has provided me opportunities to work in different countries with researchers from all over the world. As a graduate student in pharmacy-biochemistry, I was able to do an internship at Center for Neglected Diseases at Institut Pasteur Korea working on High Content Screening for Dengue and Chikungunya virus. From this work, we found compounds that inhibits the viral infection that resulted in two publications. In 2013, I started my studies in Japan, first as a research student and, from 2014 to 2018, as a PhD candidate at Department of Neuropathology at Tokyo Medical and Dental University, working on gene therapy in an animal model of a polyglutamine disease called spinocerebellar ataxia. During my time in Japan, I gained expertise in DNA damage and repair, gene therapy and adeno-associated virus. From this work, we published an article suggesting a new therapy for spinocerebellar ataxia type 1. From this publication, I received a research award at a young scientist workshop in 2017. From 2018 to 2019, I joined a new translational research program focused on the investigation of disease mechanism of inherited peripheral neuropathies (Charcot-Marie-Tooth disease, CMT) using cellular reprogramming and differentiation techniques to generate patient-specific neuronal cultures for disease modeling. Recently, I started medical school at University of Passo Fundo.